Clinverse, Inc., a global technology and eclinical commerce network for clinical trials, has formed a strategic partnership with EDC provider OmniComm Systems, Inc. to combine Clinverse’s ClinPay solution with OmniComm’s TrialMaster EDC suite.
ClinPay automates sponsor payments to clinical vendors, investigators, and other parties throughout the lifecycle of a clinical trial. OmniComm’s TrialMaster EDC suite automates data collection and data validation and offers centralized monitoring with auto-redaction and automated SDTM export utility. The goal of the combined solution is to automatically evaluate study data within the EDC system against contract criteria, and directly generate financial transactions and all related accounting information. This combination helps streamline manual processes with the goal of reducing labor costs associated with the payment and accounting process for clinical vendors and investigative sites.
“We are pleased to be in a strategic partnership with such an innovative and forward-thinking EDC provider as OmniComm,” said Steve Ayala, Clinverse president and head of strategic partnerships. “OmniComm’s global footprint expands Clinverse’s reach to a broader international audience of pharmaceutical and biotech companies, CROs, research, and medical device organizations that can greatly benefit from automated payment capabilities in conjunction with their EDC services.”
“Most of the clinical sites we work with are required to use multiple EDC systems for various studies. Two of their biggest frustrations are the lack of intuitiveness of most EDC systems and the need for accurate and timely study payments,” said Kuno van der Post, senior vice president of business development, OmniComm Systems, Inc. “Partnering with Clinverse and offering our TrialMaster EDC alongside their ClinPay solution allows us to make an exceptionally positive impact at the sites by addressing both of these key concerns.”